Semaglutide effects on alcohol use and weight
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study tests if a medication called semaglutide (used for diabetes and weight loss) can help reduce alcohol craving and drinking. It also looks at how the drug affects stress hormones and metabolism, which may help you drink less and lose weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your BMI should be between 30 and 49.9 (this counts as overweight or obese).
- You must drink alcohol at least 3 times a week and have a moderate to severe alcohol use problem.
- You need to be in generally good health and able to read and understand English.
- You cannot be taking certain psychiatric drugs, anti-obesity drugs, or opioid painkillers.
- You cannot have diabetes, thyroid cancer, pancreatitis, or a history of weight loss surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
This study tests whether semaglutide (a medication used for weight management) can help people on buprenorphine or methadone reduce their opioid use. If it works, it could provide additional support during recovery.
This study tests whether a weekly injection (a GLP-1 medication similar to semaglutide) can help people with obesity and fatty liver reduce their alcohol intake and improve liver health. It may be an option if you drink more than moderate amounts and have fatty liver.
This study tests whether a weekly medicine called semaglutide can help veterans who drink heavily reduce their alcohol intake. If you're a veteran and want to cut down on drinking, this study may be an option.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.